---
date created: 2024-11-16
dg-publish: true
tags:
  - meds
---
**Class:**
- Norepinephrine-Dopamine Reuptake Inhibitor (NDRI)

**Mechanism of Action (MOA):**
- Inhibits the reuptake of norepinephrine and dopamine, increasing their levels in the brain.

**Indications/Uses:**
- Major Depressive Disorder (MDD)
- Seasonal Affective Disorder (SAD)
- Smoking cessation (as Zyban)

**Side Effects:**
- Insomnia
- Dry mouth
- Headache
- Weight loss
- Agitation

**Adverse Effects:**
- Seizures (dose-dependent risk)
- Hypertension
- Suicidal thoughts

**Nursing Teaching and Implications:**
- Educate about the risk of seizures, particularly at higher doses.
- Advise to avoid alcohol.
- Monitor blood pressure regularly.
- Discuss the importance of not abruptly discontinuing the medication.

**Contraindications:**
- Seizure disorders
- Concurrent use with MAO inhibitors
- Known hypersensitivity to bupropion